New hope to slow advanced prostate cancer
NCT ID NCT05848011
Summary
This study is testing whether adding a new immunotherapy drug called lorigerlimab to standard chemotherapy (docetaxel) can help men with advanced prostate cancer live longer without their cancer getting worse. About 150 men whose cancer has spread and stopped responding to hormone therapy will participate. They will be randomly assigned to receive either the standard chemotherapy alone or the chemotherapy plus the new drug, and researchers will track how long it takes for the cancer to progress.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
CHP Saint Grégoire
Saint-Grégoire, France
-
CHU de Liège
Liège, Belgium
-
Centre Antoine Lacassagne
Nice, France
-
Centre Hospital de l'Ardenne
Libramont, Belgium
-
Centre Hospitalier Quimper
Quimper, France
-
Centre Léon Bérard
Lyon, France
-
Charing Cross Hospital
London, United Kingdom
-
Churchill Hospital
Headington, United Kingdom
-
Clinique Victor Hugo
Le Mans, France
-
Cliniques universitaires Saint-Luc (CUSL), Brussels
Brussels, Belgium
-
Comprehensive Cancer Center
Plovdiv, Bulgaria
-
Concord Repatriation General Hospital
Concord, Australia
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Europejskie Centrum Zdrowia Otwock, Szpital im. Fryderyka Chopina
Otwock, Poland
-
FIVO: Instituto Valenciano de Oncología
Valencia, Spain
-
First University Clinic TSMU
Tbilisi, Georgia
-
H U Germans Tries i Pujol
Barcelona, Spain
-
Hia Begin
Saint-Mandé, France
-
Hopital Foch
Suresnes, France
-
Hospital 12 de octubre
Madrid, Spain
-
Hospital Clínic de Barcelona
Barcelona, Spain
-
Hospital Parc Tauli
Barcelona, Spain
-
Hospital Sant Pau
Barcelona, Spain
-
Hospital Universitario Virgen del Rocio
Seville, Spain
-
Hospital del Mar
Barcelona, Spain
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Institut Bergonie
Bordeaux, France
-
Institut Català d'Oncologia Hospitalet_ICO Hospitalet
Barcelona, Spain
-
Institut Gustave Roussy
Villejuif, France
-
Institut Mutualiste Montsouris
Paris, France
-
LTD Consilium Medulla
Tbilisi, Georgia
-
LTD High Tech Hosp Medcenter
Batumi, Georgia
-
LTD MMT Hospital
Tbilisi, Georgia
-
LTD Todua Clinic
Tbilisi, Georgia
-
LtD L.M.National Urology Center
Tbilisi, Georgia
-
Ltd Gidmedi
Tbilisi, Georgia
-
LuxMed Onkologia
Warsaw, Poland
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
MHAT Dr. Tota Venkova
Gabrovo, Bulgaria
-
Medical Concierge
Warsaw, Poland
-
Musgrove Park Hospital
Taunton, United Kingdom
-
Nebraska Cancer Specialists
Grand Island, Nebraska, 68803, United States
-
North Shore Private Hospital
St Leonards, Australia
-
Onc. Scient. Research Center
Tbilisi, Georgia
-
Orlando Health Cancer Institute
Orlando, Florida, 32806, United States
-
Pan American Center for Oncology Trials, LLC
Rio Piedras, Puerto Rico
-
Peter MacCallum Cancer Centre
North Melbourne, Australia
-
Pratia McM Kraków
Krakow, Poland
-
Przychodnia Lekarska KOMED
Konin, Poland
-
Royal Marsden Hospital
Sutton, United Kingdom
-
START Mountain Region
West Valley City, Utah, 84119, United States
-
SUNY Upstate Medical University
Syracuse, New York, 13210, United States
-
Szpital Grochowski im. dr med. Rafała Masztaka Sp. z o.o., Oddział Chemioterapii
Warsaw, Poland
-
Szpital Woj. im M Kopernika
Koszalin, Poland
-
UMHAT Sv. Ivan Rilski
Sofia, Bulgaria
-
UZ GENT
Ghent, Belgium
-
United Medical Group
Miami, Florida, 33135, United States
-
University of Virginia Health System Cancer Center
Charlottesville, Virginia, 22903, United States
-
Vall d' Hebron Institute of Oncology (VHIO)
Barcelona, Spain
-
Westmead Hospital
Westmead, Australia
Conditions
Explore the condition pages connected to this study.